Back to top
DescriptionDateSize
Individual Sections
Overview and Control Document – Version History and Notice of Changes (Download) 2021-02-01849.56 KB
Table of Contents - Current Sections (Download) 2021-02-01101.66 KB
Section 01: Introduction (Download) 2020-06-30187.96 KB
Section 02: Documentation Requirements (Download) 2019-12-19343.88 KB
Section 03: Participant Accrual and Retention (Download) 2020-06-30198.56 KB
Section 04: Informed Consent (Download) 2019-12-19466.11 KB
Section 05: Study Procedures (Download) 2020-06-30557.19 KB
Section 06: Study Product Considerations for Non-Pharmacy Staff (Download) 2020-04-09689.44 KB
Section 07: Clinical Considerations (Download) 2020-04-09824.52 KB
Section 08: Adverse Event Reporting and Safety Monitoring (Download) 2020-06-30880.93 KB
Section 09: Counseling Considerations (Download) 2020-04-09289.5 KB
Section 10: Laboratory Considerations (Download) 2021-02-01830.49 KB
Section 11: Data Collection (Download) 2020-06-30726.43 KB
Section 12: Data Communiqués (Download) 2019-12-19133 KB
Section 12: Data Communiqué #1 (Download) 2020-02-0568.45 KB
Section 12: Data Communiqué #2 (Download) 2020-04-0961.54 KB
Section 12: Data Communiqué #3 (Download) 2020-10-2936.51 KB
Section 12: Data Communiqué #4 (Download) 2020-11-2530.03 KB
Section 12: Data Communiqué #5 (Download) 2021-01-2663.76 KB
Section 12: Data Communiqué #6 (Download) 2021-04-1854.99 KB
Section 13: Study Reporting Plan (Download) 2019-12-19302.26 KB
Section 14: DELIVER Qualitative Component (Download) 2020-04-09673.05 KB